63 related articles for article (PubMed ID: 11114644)
1. Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma.
Frilling A; Görges R; Tecklenborg K; Gassmann P; Bockhorn M; Clausen M; Broelsch CE
Surgery; 2000 Dec; 128(6):1067-74. PubMed ID: 11114644
[TBL] [Abstract][Full Text] [Related]
2. F-18 FDG PET/CT in the management of thyroid cancer.
Iagaru A; Kalinyak JE; McDougall IR
Clin Nucl Med; 2007 Sep; 32(9):690-5. PubMed ID: 17710020
[TBL] [Abstract][Full Text] [Related]
3. Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma.
Frilling A; Tecklenborg K; Görges R; Weber F; Clausen M; Broelsch EC
Ann Surg; 2001 Dec; 234(6):804-11. PubMed ID: 11729387
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic value of 18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus.
Guo H; Zhu H; Xi Y; Zhang B; Li L; Huang Y; Zhang J; Fu Z; Yang G; Yuan S; Yu J
J Nucl Med; 2007 Aug; 48(8):1251-8. PubMed ID: 17631554
[TBL] [Abstract][Full Text] [Related]
5. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
Salvatore B; Paone G; Klain M; Storto G; Nicolai E; D'Amico D; Della Morte AM; Pace L; Salvatore M
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):2-8. PubMed ID: 17538522
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer].
Lind P; Igerc I; Kohlfürst S
Wien Med Wochenschr; 2005 Oct; 155(19-20):429-35. PubMed ID: 16424998
[TBL] [Abstract][Full Text] [Related]
7. [Thyroglobulin levels in needle lymph node cytology for the detection of papillary thyroid cancer recurrence].
Véliz J; Brantes S; Ramos C; Aguayo J; Cáceres E; Herrera M; Barber A; Barría M; Wohllk N
Rev Med Chil; 2008 Sep; 136(9):1107-12. PubMed ID: 19030653
[TBL] [Abstract][Full Text] [Related]
8. Clinical implication of F-18 FDG PET/CT for differentiated thyroid cancer in patients with negative diagnostic iodine-123 scan and elevated thyroglobulin.
Kim SJ; Lee TH; Kim IJ; Kim YK
Eur J Radiol; 2009 Apr; 70(1):17-24. PubMed ID: 18207685
[TBL] [Abstract][Full Text] [Related]
9. Combined positron emission tomography/computed tomography imaging of recurrent thyroid cancer.
Zimmer LA; McCook B; Meltzer C; Fukui M; Bascom D; Snyderman C; Townsend DW; Johnson JT
Otolaryngol Head Neck Surg; 2003 Feb; 128(2):178-84. PubMed ID: 12601311
[TBL] [Abstract][Full Text] [Related]
10. [Positron emission tomography-computed tomography with (18)F-fluorodeoxyglucose in patients with recurrent differentiated thyroid carcinoma and negative radioiodine scan. Diagnostic performance and relation with tyroglobulin levels].
Mariscal Labrador E; García Burillo A; Castell-Conesa J; Obiols Alfonso G; Kisiel González N; Barios Profitós M; Aguadé-Bruix S; Mesa Manteca J
Rev Esp Med Nucl Imagen Mol; 2013; 32(3):146-51. PubMed ID: 22726673
[TBL] [Abstract][Full Text] [Related]
11. [Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer].
Pöpperl G; Lang S; Dagdelen O; Jäger L; Tiling R; Hahn K; Tatsch K
Rofo; 2002 Jun; 174(6):714-20. PubMed ID: 12063600
[TBL] [Abstract][Full Text] [Related]
12. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma.
Frasoldati A; Pesenti M; Gallo M; Caroggio A; Salvo D; Valcavi R
Cancer; 2003 Jan; 97(1):90-6. PubMed ID: 12491509
[TBL] [Abstract][Full Text] [Related]
14. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
15. Postoperative surveillance of differentiated thyroid carcinoma: rationale, techniques, and controversies.
Johnson NA; Tublin ME
Radiology; 2008 Nov; 249(2):429-44. PubMed ID: 18936309
[TBL] [Abstract][Full Text] [Related]
16. A new approach for standardization and increased accuracy of lymph node washout thyroglobulin in patients with differentiated thyroid carcinoma.
Aydin C; Ozdemir D; Sacikara M; Polat SB; Yazgan AK; Turkolmez S; Onal ED; Ersoy R; Cakir B
Diagn Cytopathol; 2016 Mar; 44(3):177-86. PubMed ID: 26685703
[TBL] [Abstract][Full Text] [Related]
17. [Thermography in the diagnosis of thyroid neoplasms].
Kuz'michev AS
Vopr Onkol; 1981; 27(11):33-7. PubMed ID: 7336665
[TBL] [Abstract][Full Text] [Related]
18. Sonography in the follow-up of 100 patients with thyroid carcinoma.
Simeone JF; Daniels GH; Hall DA; McCarthy K; Kopans DB; Butch RJ; Mueller PR; Stark DD; Ferrucci JT; Wang CA
AJR Am J Roentgenol; 1987 Jan; 148(1):45-9. PubMed ID: 3538834
[TBL] [Abstract][Full Text] [Related]
19. Detection of disease recurrence in differentiated thyroid cancer.
Shin JJ; Milas M
Minerva Chir; 2010 Feb; 65(1):101-16. PubMed ID: 20212422
[TBL] [Abstract][Full Text] [Related]
20. Suture granuloma mimicking recurrent thyroid carcinoma on ultrasonography.
Chung YE; Kim EK; Kim MJ; Yun M; Hong SW
Yonsei Med J; 2006 Oct; 47(5):748-51. PubMed ID: 17066522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
